Antibiofilm and Antivirulence Efficacies of Flavonoids and Curcumin Against

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2019 May 29

PMID 31134028

Citations 53

Authors

Chaitany Jayprakash Raorane

Jin-Hyung Lee

Yong-Guy Kim

Satish Kumar Rajasekharan

Rodolfo Garcia-Contreras

Jintae Lee

Affiliations

Soon will be listed here.

Abstract

is well adapted to hospital environments, and the persistence of its chronic infections is mainly due to its ability to form biofilms resistant to conventional antibiotics and host immune systems. Hence, the inhibitions of biofilm formation and virulence characteristics provide other means of addressing infections. In this study, the antibiofilm activities of twelve flavonoids were initially investigated. Three most active flavonoids, namely, fisetin, phloretin, and curcumin, dose-dependently inhibited biofilm formation by a reference strain and by several clinical isolates, including four multidrug-resistant isolates. Furthermore, the antibiofilm activity of curcumin (the most active flavonoid) was greater than that of the well-known biofilm inhibitor gallium nitrate. Curcumin inhibited pellicle formation and the surface motility of . Interestingly, curcumin also showed antibiofilm activity against and mixed cultures of and . molecular docking of the biofilm response regulator BfmR showed that the binding efficacy of flavonoids with BfmR was correlated with antibiofilm efficacy. In addition, curcumin treatment diminished virulence in an model without cytotoxicity. The study shows curcumin and other flavonoids have potential for controlling biofilm formation by and the virulence of .

Citing Articles

Synergistic antibacterial activity of curcumin and phage against multidrug-resistant Acinetobacter baumannii.

Janesomboon S, Sawaengwong T, Muangsombut V, Vanaporn M, Santanirand P, Kritsiriwuthinan K Sci Rep. 2025; 15(1):8959.

PMID: 40089540 DOI: 10.1038/s41598-025-94040-y.

Breaking the Phalanx: Overcoming Bacterial Drug Resistance with Quorum Sensing Inhibitors that Enhance Therapeutic Activity of Antibiotics.

Beasley J, Dorjsuren D, Jain S, Rath M, Tieghi R, Tropsha A bioRxiv. 2025; .

PMID: 39896648 PMC: 11785035. DOI: 10.1101/2025.01.17.633658.

Platforms for the Search for New Antimicrobial Agents Using In Vivo C. elegans Models.

Kalganova A, Eliseev I, Smirnov I, Terekhov S Acta Naturae. 2025; 16(4):15-26.

PMID: 39877009 PMC: 11771841. DOI: 10.32607/actanaturae.27348.

Evaluation of Cinnamon Essential Oil and Its Emulsion on Biofilm-Associated Components of Clinical Strains.

Ganic T, Pecinar I, Nikolic B, Kekic D, Tomic N, Cvetkovic S Antibiotics (Basel). 2025; 14(1).

PMID: 39858391 PMC: 11761628. DOI: 10.3390/antibiotics14010106.

Repurposing Plant-Based Histone Acetyltransferase Inhibitors: A Review of Novel Therapeutic Strategies Against Drug-Resistant Fungal Biofilms.

Saravanan T, Raorane C, Ravichandran V, Rajasekharan S Curr Microbiol. 2024; 82(1):1.

PMID: 39532708 DOI: 10.1007/s00284-024-03971-8.

References

Costerton J, Stewart P, Greenberg E . Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284(5418):1318-22. DOI: 10.1126/science.284.5418.1318. View

Merken H, Beecher G . Liquid chromatographic method for the separation and quantification of prominent flavonoid aglycones. J Chromatogr A. 2000; 897(1-2):177-84. DOI: 10.1016/s0021-9673(00)00826-8. View

Tomaras A, Dorsey C, Edelmann R, Actis L . Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology (Reading). 2003; 149(Pt 12):3473-3484. DOI: 10.1099/mic.0.26541-0. View

Duarte S, Gregoire S, Singh A, Vorsa N, Schaich K, Bowen W . Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms. FEMS Microbiol Lett. 2006; 257(1):50-6. DOI: 10.1111/j.1574-6968.2006.00147.x. View

Mussi M, Gaddy J, Cabruja M, Arivett B, Viale A, Rasia R . The opportunistic human pathogen Acinetobacter baumannii senses and responds to light. J Bacteriol. 2010; 192(24):6336-45. PMC: 3008525. DOI: 10.1128/JB.00917-10. View

Marti S, Rodriguez-Bano J, Catel-Ferreira M, Jouenne T, Vila J, Seifert H . Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species. BMC Res Notes. 2011; 4:5. PMC: 3023692. DOI: 10.1186/1756-0500-4-5. View

Pour N, Dusane D, Dhakephalkar P, Zamin F, Zinjarde S, Chopade B . Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. FEMS Immunol Med Microbiol. 2011; 62(3):328-38. DOI: 10.1111/j.1574-695X.2011.00818.x. View

Clemmer K, Bonomo R, Rather P . Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology (Reading). 2011; 157(Pt 9):2534-2544. PMC: 3352170. DOI: 10.1099/mic.0.049791-0. View

Lee J, Regmi S, Kim J, Cho M, Yun H, Lee C . Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect Immun. 2011; 79(12):4819-27. PMC: 3232668. DOI: 10.1128/IAI.05580-11. View

10.

Eijkelkamp B, Stroeher U, Hassan K, Papadimitrious M, Paulsen I, Brown M . Adherence and motility characteristics of clinical Acinetobacter baumannii isolates. FEMS Microbiol Lett. 2011; 323(1):44-51. DOI: 10.1111/j.1574-6968.2011.02362.x. View

11.

Howard A, ODonoghue M, Feeney A, Sleator R . Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence. 2012; 3(3):243-50. PMC: 3442836. DOI: 10.4161/viru.19700. View

12.

Lee J, Park J, Cho M, Lee J . Flavone reduces the production of virulence factors, staphyloxanthin and α-hemolysin, in Staphylococcus aureus. Curr Microbiol. 2012; 65(6):726-32. DOI: 10.1007/s00284-012-0229-x. View

13.

Thompson R, Bobay B, Stowe S, Olson A, Peng L, Su Z . Identification of BfmR, a response regulator involved in biofilm development, as a target for a 2-Aminoimidazole-based antibiofilm agent. Biochemistry. 2012; 51(49):9776-8. PMC: 3567222. DOI: 10.1021/bi3015289. View

14.

Liou M, Soo P, Ling S, Kuo H, Tang C, Chang K . The sensor kinase BfmS mediates virulence in Acinetobacter baumannii. J Microbiol Immunol Infect. 2013; 47(4):275-81. DOI: 10.1016/j.jmii.2012.12.004. View

15.

Beceiro A, Moreno A, Fernandez N, Vallejo J, Aranda J, Adler B . Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob Agents Chemother. 2013; 58(1):518-26. PMC: 3910726. DOI: 10.1128/AAC.01597-13. View

16.

Abuelsaad A, Allam G, Al-Solumani A . Hesperidin inhibits inflammatory response induced by Aeromonas hydrophila infection and alters CD4+/CD8+ T cell ratio. Mediators Inflamm. 2014; 2014:393217. PMC: 4033591. DOI: 10.1155/2014/393217. View

17.

Betts J, Wareham D . In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii. BMC Microbiol. 2014; 14:172. PMC: 4083870. DOI: 10.1186/1471-2180-14-172. View

18.

Lee K, Lee J, Ryu S, Cho M, Lee J . Stilbenes reduce Staphylococcus aureus hemolysis, biofilm formation, and virulence. Foodborne Pathog Dis. 2014; 11(9):710-7. DOI: 10.1089/fpd.2014.1758. View

19.

Nait Chabane Y, Marti S, Rihouey C, Alexandre S, Hardouin J, Lesouhaitier O . Characterisation of pellicles formed by Acinetobacter baumannii at the air-liquid interface. PLoS One. 2014; 9(10):e111660. PMC: 4216135. DOI: 10.1371/journal.pone.0111660. View

20.

Wu H, Moser C, Wang H, Hoiby N, Song Z . Strategies for combating bacterial biofilm infections. Int J Oral Sci. 2014; 7(1):1-7. PMC: 4817533. DOI: 10.1038/ijos.2014.65. View